Fluctuating pain in Parkinson's disease: Its prevalence and impact on quality of life

Roh, 2009, The relationship of pain and health-related quality of life in Korean patients with Parkinson’s disease, Acta Neurol Scand, 119, 397, 10.1111/j.1600-0404.2008.01114.x Wasner, 2012, Pains in Parkinson disease--many syndromes under one umbrella, Nat. Rev. Neurol., 8, 284, 10.1038/nrneurol.2012.54 Broen, 2012, Prevalence of pain in Parkinson’s disease: a systematic review using the modified QUADAS tool, Mov. Disord., 27, 480, 10.1002/mds.24054 Ford, 2010, Pain in Parkinson’s disease, Mov. Disord., 25 Ford, 1998, Pain in Parkinson's disease, Clin. Neurosci., 5, 63 Tseng, 2017, Pain in early-stage Parkinson's disease: Implications from clinical features to pathophysiology mechanisms, J. Formos. Med. Assoc., 116, 571, 10.1016/j.jfma.2017.04.024 Nebe, 2009, Pain intensity on and off levodopa in patients with Parkinson's disease, Mov. Disord., 24, 1233, 10.1002/mds.22546 Storch, 2013, Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications, Neurology., 80, 800, 10.1212/WNL.0b013e318285c0ed Postuma, 2015, MDS clinical diagnostic criteria for Parkinson's disease, Mov. Disord., 30, 1591, 10.1002/mds.26424 Hoehn, 1967, Parkinsonism: onset, progression and mortality, Neurology, 50, 427, 10.1212/WNL.17.5.427 Kashihara, 2014, Official Japanese version of the International Parkinson and Movement Disorder Society–Unified Parkinson’s Disease Rating Scale: validation against the original English version, Mov Disord Clin Pract (Hoboken), 1, 200, 10.1002/mdc3.12058 Nasreddine, 2005, The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment, J Am Geriatr Soc, 53, 695, 10.1111/j.1532-5415.2005.53221.x Fujiwara, 2010, Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal cognitive assessment, Geriatr Gerontol Int, 10, 225, 10.1111/j.1447-0594.2010.00585.x Zung, 1965, A self-rating depression scale, Arch. Gen. Psychiatry, 12, 63, 10.1001/archpsyc.1965.01720310065008 Stacy, 2008, The sensitivity and specificity of the 9-item wearing-off questionnaire, Parkinsonism Relat Disord, 14, 205, 10.1016/j.parkreldis.2007.07.013 Kondo, 2011, Translation and linguistic validation of the Japanese version of the wearing-off questionnaires (WOQ-19 and WOQ-9), Brain Nerve, 63, 1285 Fukae, 2015, Utility of the Japanese version of the 9-item wearing-off questionnaire, Clin Neurol Neurosurg, 134, 110, 10.1016/j.clineuro.2015.04.021 Peto, 1995, The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease, Qual. Life. Res., 4, 241, 10.1007/BF02260863 Jenkinson, 1997, The PDQ-8: Development and validation of a short-form Parkinson's disease questionnaire, Psychol. Health, 12, 805, 10.1080/08870449708406741 Mizuno, 2018, Long-term treatment of Parkinson's disease with levodopa and other adjunctive drugs, J. Neural. Transm. (Vienna), 125, 35, 10.1007/s00702-016-1671-x Warren, 2013, Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson’s disease, Mov Disord, 28, 1064, 10.1002/mds.25364 Ferguson, 2016, Early-onset vs. Late-onset Parkinson's disease: A Clinical-pathological Study, Can. J. Neurol. Sci., 43, 113, 10.1017/cjn.2015.244 Rodríguez-Violante, 2017, Clinical determinants of Parkinson's disease-associated pain using the King's Parkinson's Disease Pain Scale, Mov. Disord. Clin. Pract., 4, 545, 10.1002/mdc3.12469 Wan, 2020, Wearing-off identification in Parkinson’s disease: the shapd-woq study, Front Neurol, 11, 116, 10.3389/fneur.2020.00116 Tran, 2018, Levodopa-induced dyskinesia: clinical features, incidence, and risk factors, J. Neural. Transm (Vienna), 125, 1109, 10.1007/s00702-018-1900-6 Lim, 2008, Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson’s disease?, Mov. Disord., 23, 1689, 10.1002/mds.22111 Antonini, 2008, The PRIAMO study: background, methods and recruitment, Neurol. Sci., 29, 61, 10.1007/s10072-008-0863-z Jasinska-Myga, 2010, Depression in Parkinson’s disease, Can. J. Neurol. Sci., 37, 61, 10.1017/S0317167100009665 Piardi, 2020, Social stress as a trigger for depressive-like behavior and persistent hyperalgesia in mice: study of the comorbidity between depression and chronic pain, J Affect Disord, 1, 759, 10.1016/j.jad.2020.05.144 Hilderink, 2012, The temporal relation between pain and depression: results from the longitudinal aging study Amsterdam, Psychosom. Med., 74, 945, 10.1097/PSY.0b013e3182733fdd Barnes, 2001, Visual hallucinations in Parkinson’s disease: a review and phenomenological survey, J Neurol Neurosurg Psychiatry, 70, 727, 10.1136/jnnp.70.6.727 Russo, 2019, The pharmacology of visual hallucinations in yynucleinopathies, Front Pharmacol, 10, 1379, 10.3389/fphar.2019.01379 Chaudhuri, 2009, Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment, Lancet Neurol, 8, 464, 10.1016/S1474-4422(09)70068-7 Valkovic, 2015, Pain in Parkinson’s disease: a cross-sectional study of its prevalence, types, and relationship to depression and quality of life, PLoS One, 10, 10.1371/journal.pone.0136541 Rahman, 2008, Quality of life in Parkinson's disease: the relative importance of the symptoms, Mov. Disord., 23, 1428, 10.1002/mds.21667 Choi, 2017, Impact of pain and pain subtypes on the quality of life of patients with Parkinson’s disease, J Clin Neurosci, 45, 105, 10.1016/j.jocn.2017.08.002 Muangpaisan, 2009, Systematic review of the prevalence and incidence of Parkinson’s disease, Asia J Epidemiol, 19, 281, 10.2188/jea.JE20081034 Armstrong, 2020, Diagnosis and treatment of Parkinson disease: a review, JAMA., 323, 548, 10.1001/jama.2019.22360 Kamel, 2020, LCIG in treatment of non-motor symptoms in advanced Parkinson’s disease: review of literature, Brain Behav, 10, 10.1002/brb3.1757 Dafsari, 2018, Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease, Brain Stimul., 11, 867, 10.1016/j.brs.2018.02.015 Barone, 2009, The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease, Mov Disord, 24, 1641, 10.1002/mds.22643 Rodríguez-Violante, 2017, Clinical determinants of Parkinson’s disease-associated pain using the King’s Parkinson’s disease pain scale, Mov Disord Clin Pract, 4, 545, 10.1002/mdc3.12469